Amesite Inc. $AMST
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Services-Prepackaged Software
- Headquarters
- Ann Arbor, MI
- Fiscal year end
- June 30
- Shares outstanding
- 6,549,851 [10-K 2026-09-23]
What the company doesAI summary of filing
Amesite is a technology company that develops and sells artificial intelligence-powered software solutions for the healthcare industry, with a focus on the post-acute care market. The company operates two main product lines: NurseMagic™, which serves both individual healthcare professionals (B2C) and healthcare businesses including home health, skilled nursing, and hospice operations (B2B), and LynkMagic™, which provides enterprise AI solutions for healthcare organizations. The company generates revenue through subscription-based pricing tiers for NurseMagic™ and enterprise deployments of LynkMagic™, with individual users able to access a free version of NurseMagic™. As of fiscal 2026, the company is revenue-generating and deployed its largest enterprise implementation to date, serving approximately 2,700-patient census. [10-K 2026-09-23]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| FY ended Jun 2026 | $364.8K | −$3.10M | −$2.15M | $2.30M | [10-K 2026-09-23] |
| FY ended Jun 2025 | $110.5K | −$6.62M | −$2.46M | $2.33M | [10-K 2026-09-23] |
- Quarterly cash burn
- −$536.7K
- Cash runway Estimate
- ~12.9 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-14 | 2,792,440 | [10-Q/A 2025-01-02] |
| 2025-02-05 | 3,994,107 | [10-Q 2025-02-07] |
| 2025-05-15 | 4,572,713 | [10-Q 2025-05-15] |
| 2025-09-29 | 4,572,713 | [10-K 2025-09-29] |
| 2025-10-24 | 4,572,713 | [10-K/A 2025-10-28] |
| 2026-02-05 | 4,572,713 | [10-Q 2026-02-06] |
| 2026-05-18 | 5,852,985 | [10-Q 2026-05-18] |
| 2026-09-23 | 6,549,851 | [10-K 2026-09-23] |
- Shelf registration
- S-1 filed 2026-05-12; declared effective 2026-05-28 [S-1 2026-05-12]
Listing status
Current status: 2 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2025-10-29. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2025-10-29 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-10-29] |
| 2024-12-03 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2024-12-03] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-02 | PRE 14A | Proxy statement |
| 2026-09-23 | 10-K | Annual report |
| 2026-09-17 | 8-K | Other events |
| 2026-09-11 | 8-K | Regulation FD disclosure |
| 2026-07-20 | 8-K | Material agreement entered |
| 2026-07-17 | 424B5 | Prospectus or prospectus supplement |
| 2026-07-13 | 8-K | Director or officer change; Shareholder vote results |
| 2026-06-03 | DEF 14A | Proxy statement |
| 2026-05-26 | S-1/A | Registration statement |
| 2026-05-19 | 8-K | Other events |
| 2026-05-18 | 10-Q | Quarterly report |
| 2026-05-15 | NT 10-Q | Notice of late quarterly report |
Alerts for $AMST
Email me when Amesite Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.